BioSpace News Archive

Shattuck Labs, Inc. today announced it will present a poster on its bispecific Gamma Delta T Cell Engager (GADLEN) platform at SITC’s 37th Annual Meeting being held November 8th – 12th, 2022.

LadRx Corporation announced it is changing its OTCQB ticker symbol from CYTR to LADX effective Thursday, October 6, 2022.

BIOQUAL, Inc., Announces Promotion of Mr. Charles C. Kirk, Jr., CPA. to the Position of Chief Financial Officer.

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today filing of a provisional patent application with the USPTO entitled " Enhancement of T Cell Homing to Tumors Through Augmentation of Chemokine Responsiveness and Activation Dependent Chemokine Secretion” with the United States Patent and Trademark Office.

The latest market analysis report published by Reports and Data, titled ‘Global Alopecia Market – Forecast to 2030,’ thoroughly examines the Alopecia industry to provide essential data & information for the targeted readers.

Arcutis Biotherapeutics, Inc. reported the grant of an aggregate of 32,300 restricted stock units of Arcutis’ common stock as well as options to purchase an aggregate of 85,800 shares of Arcutis’ common stock to nine newly hired employees.

Atreca, Inc. today announced two poster presentations at the SITC 2022 Annual Meeting, being held November 8-12 in Boston, Massachusetts.

Bayer Inc. announced that Health Canada, following a priority review, has approved NUBEQA® for the treatment of patients with metastatic castration-sensitive prostate cancer in combination with docetaxel1.

Conformis, Inc. announced today it will release its financial results for the third quarter ended September 30, 2022, after the market closes on Wednesday, November 2, 2022.

Cellectis announced today that pre-clinical data on TALEN ® -edited smart CAR T-cells to overcome key challenges of targeting solid tumors, will be presented at the Society for Immunotherapy of Cancer’s 37th Annual Meeting (SITC 2022), to be held in Boston, M.A.